Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2023-04-12 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2023-04-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is extremely short (241 characters) and contains no substantive financial data, analysis, or report content. It appears to be a digital signature or certification by an individual named Jai Vaidya dated April 7, 2023. There is no indication of a full report, announcement, or detailed filing. Given the nature of the content, this fits the criteria for a Regulatory Filing (RNS) as an officer certification or attestation rather than a full report or announcement.
2023-04-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is extremely short (356 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. It does not fit any specific report category and appears to be a regulatory or compliance-related filing with minimal content. According to the rules, such minimal content documents default to Regulatory Filings (RNS).
2023-03-30 English
Price movement
Regulatory Filings Classification · 100% confidence The document text is extremely short (78 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed filing. Given the lack of content, this document best fits the fallback category for miscellaneous filings or certifications, which is Regulatory Filings (RNS).
2023-03-20 English
Updates
Capital/Financing Update Classification · 95% confidence The document text is very short (395 characters) and contains details about a rights issue of equity shares, including the type of securities, type of issuance, size, and record date. This clearly indicates an announcement related to a capital raising activity. There is no indication of a full report or financial statements, just an update on a financing event. Therefore, the document fits the category of Capital/Financing Update (CAP).
2023-03-04 English
Shareholders meeting
Regulatory Filings
2023-03-04 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.